Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
May 7, 2009
Human drug hepatotoxicity: a contemporary clinical perspective
David N Assis, Victor J Navarro
The Lancet. Gastroenterology & Hepatology
|
October 31, 2025
Ileal bile acid transporter inhibitors for cholestatic pruritus in primary biliary cholangitis
Ansgar W Lohse, David N Assis
Pediatric Pulmonology
|
August 6, 2024
Pathophysiology of Cystic Fibrosis Liver Disease
Vania L Kasper, David N Assis
Hepatology (Baltimore, Md.)
|
December 19, 2019
Machine Learning in a Complex Disease: PREsTo Improves the Prognostication of Primary Sclerosing Cholangitis
Dennis L Shung, David N Assis
Clinics in Chest Medicine
|
November 7, 2022
Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis
Christopher Vélez, Steven D Freedman, David N Assis
Methods in Molecular Biology (Clifton, N.J.)
|
April 25, 2019
Patient-Derived Organoids from Human Bile: An In Vitro Method to Study Cholangiopathies
Carol J Soroka, David N Assis, James L Boyer
Hepatology (Baltimore, Md.)
|
February 14, 2015
Fibrates and cholestasis
Nisanne S Ghonem, David N Assis, James L Boyer
Current Opinion in Rheumatology
|
September 8, 2025
A comprehensive review of systemic sclerosis-primary biliary cholangitis overlap: emerging evidence for a distinct clinical subtype
Areeka Memon, Manvitha Nadella, Morgan Emokpae, et al.
Seminars in Liver Disease
|
June 22, 2019
The Contribution of B Cells in Autoimmune Liver Diseases
Sarah A Taylor, David N Assis, Cara L Mack
Journal of Clinical Gastroenterology
|
September 8, 2011
Successful treatment of a bleeding umbilical varix by percutaneous umbilical vein embolization with sclerotherapy
David N Assis, Jeffrey Pollak, Michael L Schilsky, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
Expert Opinion on Drug Metabolism & Toxicology
|
May 7, 2009
Human drug hepatotoxicity: a contemporary clinical perspective
David N Assis, Victor J Navarro
The Lancet. Gastroenterology & Hepatology
|
October 31, 2025
Ileal bile acid transporter inhibitors for cholestatic pruritus in primary biliary cholangitis
Ansgar W Lohse, David N Assis
Pediatric Pulmonology
|
August 6, 2024
Pathophysiology of Cystic Fibrosis Liver Disease
Vania L Kasper, David N Assis
Hepatology (Baltimore, Md.)
|
December 19, 2019
Machine Learning in a Complex Disease: PREsTo Improves the Prognostication of Primary Sclerosing Cholangitis
Dennis L Shung, David N Assis
Clinics in Chest Medicine
|
November 7, 2022
Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis
Christopher Vélez, Steven D Freedman, David N Assis
Methods in Molecular Biology (Clifton, N.J.)
|
April 25, 2019
Patient-Derived Organoids from Human Bile: An In Vitro Method to Study Cholangiopathies
Carol J Soroka, David N Assis, James L Boyer
Hepatology (Baltimore, Md.)
|
February 14, 2015
Fibrates and cholestasis
Nisanne S Ghonem, David N Assis, James L Boyer
Current Opinion in Rheumatology
|
September 8, 2025
A comprehensive review of systemic sclerosis-primary biliary cholangitis overlap: emerging evidence for a distinct clinical subtype
Areeka Memon, Manvitha Nadella, Morgan Emokpae, et al.
Seminars in Liver Disease
|
June 22, 2019
The Contribution of B Cells in Autoimmune Liver Diseases
Sarah A Taylor, David N Assis, Cara L Mack
Journal of Clinical Gastroenterology
|
September 8, 2011
Successful treatment of a bleeding umbilical varix by percutaneous umbilical vein embolization with sclerotherapy
David N Assis, Jeffrey Pollak, Michael L Schilsky, et al.
Page
of 6